298 related articles for article (PubMed ID: 10349985)
41. Tumour stage, node stage, p53 gene status, and bcl-2 protein expression as predictors of tumour response to platin-fluorouracil chemotherapy in patients with squamous-cell carcinoma of the head and neck.
Fouret P; Temam S; Charlotte F; Lacau-St-Guily J
Br J Cancer; 2002 Dec; 87(12):1390-5. PubMed ID: 12454767
[TBL] [Abstract][Full Text] [Related]
42. [Impact of the sentinel lymph node in the staging of colorectal carcinoma].
Pozza E; Ascanelli S; Turini A; Tonini G; Carcoforo P; Navarra G
Chir Ital; 2002; 54(5):659-65. PubMed ID: 12469463
[TBL] [Abstract][Full Text] [Related]
43. Sentinel lymph node evaluation does not improve staging accuracy in colon cancer.
Lim SJ; Feig BW; Wang H; Hunt KK; Rodriguez-Bigas MA; Skibber JM; Ellis V; Cleary K; Chang GJ
Ann Surg Oncol; 2008 Jan; 15(1):46-51. PubMed ID: 17985187
[TBL] [Abstract][Full Text] [Related]
44. Can depth of tumour invasion predict lymph node positivity in patients undergoing resection for early rectal cancer? A comparative study between T1 and T2 cancers.
Rasheed S; Bowley DM; Aziz O; Tekkis PP; Sadat AE; Guenther T; Boello ML; McDonald PJ; Talbot IC; Northover JM
Colorectal Dis; 2008 Mar; 10(3):231-8. PubMed ID: 18257848
[TBL] [Abstract][Full Text] [Related]
45. Differences in AgNOR quantity between colorectal cancer and corresponding metastases: are they useful for prognostic purposes?
Giuffrè G; Barresi G; Speciale G; Sarnelli R; Gioffrè Florio MA; Tuccari G
Eur J Histochem; 1997; 41(2):111-8. PubMed ID: 9271703
[TBL] [Abstract][Full Text] [Related]
46. Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer.
Zlobec I; Minoo P; Baumhoer D; Baker K; Terracciano L; Jass JR; Lugli A
Cancer; 2008 Feb; 112(3):495-502. PubMed ID: 18076013
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma.
Ferrari S; Bertoni F; Zanella L; Setola E; Bacchini P; Alberghini M; Versari M; Bacci G
Cancer; 2004 May; 100(9):1936-42. PubMed ID: 15112275
[TBL] [Abstract][Full Text] [Related]
48. Tumor invasion of lymph node capsules in patients with Dukes C colorectal adenocarcinoma.
Yano H; Saito Y; Kirihara Y; Takashima J
Dis Colon Rectum; 2006 Dec; 49(12):1867-77. PubMed ID: 17080279
[TBL] [Abstract][Full Text] [Related]
49. [Effect of overexpression of P53 protein in colorectal carcinoma on short-term prognosis].
Domínguez Iglesias F; Riera Velasco JR; Junco Petrement P; Tojo Ramallo P; Díaz-Faes Cervero M
Rev Esp Enferm Dig; 1994 Nov; 86(5):796-802. PubMed ID: 7848689
[TBL] [Abstract][Full Text] [Related]
50. Prediction of nodal metastasis and prognosis in breast cancer: a neural model.
Naguib RN; Adams AE; Horne CH; Angus B; Smith AF; Sherbet GV; Lennard TW
Anticancer Res; 1997; 17(4A):2735-41. PubMed ID: 9252707
[TBL] [Abstract][Full Text] [Related]
51. Tumour differentiation grade is associated with TNM staging and the risk of node metastasis in colorectal cancer.
Derwinger K; Kodeda K; Bexe-Lindskog E; Taflin H
Acta Oncol; 2010; 49(1):57-62. PubMed ID: 20001500
[TBL] [Abstract][Full Text] [Related]
52. Bcl-2 expression as a prognostic factor of survival of gastric carcinoma.
Inada T; Kikuyama S; Ichikawa A; Igarashi S; Ogata Y
Anticancer Res; 1998; 18(3B):2003-10. PubMed ID: 9677457
[TBL] [Abstract][Full Text] [Related]
53. The correlation between the immunostains for p53 and Ki67 with bcl-2 expression and classical prognostic factors in colorectal carcinomas.
Gurzu S; Jung J; Mezei T; Pávai Z
Rom J Morphol Embryol; 2007; 48(2):95-9. PubMed ID: 17641794
[TBL] [Abstract][Full Text] [Related]
54. Predictive model of outcome of targeted nodal assessment in colorectal cancer.
Nissan A; Protic M; Bilchik A; Eberhardt J; Peoples GE; Stojadinovic A
Ann Surg; 2010 Feb; 251(2):265-74. PubMed ID: 20054276
[TBL] [Abstract][Full Text] [Related]
55. [Expression of phosphatase of regeneration liver-3 in human colorectal carcinoma and its prognosis value].
Zhao GP; Zhou ZG; Lei WZ; Wang C; Zheng XL; Zheng YC
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):487-91. PubMed ID: 18803057
[TBL] [Abstract][Full Text] [Related]
56. The use of molecular markers as a method to predict the response to neoadjuvant therapy for advanced stage rectal adenocarcinoma.
Edden Y; Wexner SD; Berho M
Colorectal Dis; 2012 May; 14(5):555-61. PubMed ID: 21689364
[TBL] [Abstract][Full Text] [Related]
57. Accuracy of tumor grade by preoperative curettage and associated clinicopathologic factors in clinical stage I endometriod adenocarcinoma.
Wang XY; Pan ZM; Chen XD; Lü WG; Xie X
Chin Med J (Engl); 2009 Aug; 122(16):1843-6. PubMed ID: 19781357
[TBL] [Abstract][Full Text] [Related]
58. [A comparative study on the prognostic value of the nuclear expression of protein p53 vis-à-vis histopathology in colorectal cancer].
Díez M; Camuñas J; Enríquez JM; González A; Torabuela E; Gutiérrez A; Ratia T; Mugüerza JM; Martín A; Ruiz A; Granell J
An Med Interna; 1996 May; 13(5):222-6. PubMed ID: 8767868
[TBL] [Abstract][Full Text] [Related]
59. A clinical nomogram predicting pathologic lymph node involvement in esophageal cancer patients.
Gaur P; Sepesi B; Hofstetter WL; Correa AM; Bhutani MS; Vaporciyan AA; Watson TJ; Swisher SG;
Ann Surg; 2010 Oct; 252(4):611-7. PubMed ID: 20881767
[TBL] [Abstract][Full Text] [Related]
60. Does p53 overexpression cause metastases in early invasive colorectal adenocarcinoma?
Sory A; Minamoto T; Ohta T; Yamashita K; Sawaguchi K; Mai M; Misiuna P
Eur J Surg; 1997 Sep; 163(9):685-92. PubMed ID: 9311476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
